Advertisement
Advertisement

ENLV

ENLV logo

Enlivex Ltd. Ordinary Shares

1.52
USD
Sponsored
+0.01
+0.66%
Aug 25, 15:59 UTC -4
Closed
exchange

Pre-Market

1.58

+0.06
+3.95%

Enlivex Ltd. Ordinary Shares Profile

About

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company principally in Israel. Its product pipeline includes the Allocetra which is in clinical trial. Enlivex Ltd., formerly known as Enlivex Therapeutics Ltd., is based in Ness Ziona, Israel.

Info & Links

CEO

Oren Hershkovitz

Headquarters

14 Einstein Street
Ness Ziona, L3 7403618, ISRAEL

Industry

Medical Drugs

Sector

Medical

Website

www.enlivex.com

Auditor

Yarel & Partners

Share holders

--

Employees

34

Enlivex Ltd. Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

27.63M

Enterprise Value

26.12M

Enterprise Value/EBITDA(ttm)

-1.78

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

248.08%

Return on Invested Capital(ttm)

25.08%

Return on Assets(ttm)

206.39%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-14.70M

Net Income Available to Common(ttm)

1.24B

Diluted EPS(ttm)

-8.25

Share Statistics

Beta (5Y Monthly)

1.60

52-Week Change

-90.62%

S&P 500 52-Week Change

19.04%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

15.83M

Dividend Yield

0.00%

Float4

15.34M

% Held by Insiders

12.28%

% Held by Institutions

1.02%

Balance Sheet

Total Cash(mrq)

1.74B

Total Cash Per Share(mrq)

109.82

Total Debt(mrq)

383.00K

Total Debt/Equity(mrq)

0.02%

Current Ratio(mrq)

193.24%

Quick Ratio(mrq)

193.24%

Book Value Per Share(mrq)

122.21

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.22

Free Cash Flow(ytd)

-10.48M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement